Pharma
The Copenhagen-based digital health company will work with Novartis to build digital health tools for chronic conditions where they see unmet needs and the potential for disease progression.
According to a review of studies in the Lancet Digital Health, "a real risk of reidentification exists" when sharing data from wearable devices.
Diathrive Health users will have access to Mark Cuban Cost Plus Drug Company's lower-cost diabetes medication and testing supplies.
The Digital Medicine Society partnered with digital health and pharma players like the FDA, Janssen, GSK, Medable and THREAD to build a toolkit aimed at improving diversity in digital research.
Marker Learning, which provides virtual assessments for learning disabilities, raised $15 million, and reproductive care company Twentyeight Health scored $8.3 million.
The funds will help the company grow its platform and scale partnerships with life science companies and healthcare systems.
National Center for Health Workforce Planning CEO Ziad Nakshabandi discusses the reskilling and upskilling of healthcare workers and how that effort aligns with the Kingdom's Vision 2030 objectives.
The grocery chain's healthcare division also announced its first trial, a collaboration with Persephone Biosciences.
RxPass, which will be available to Prime members, will offer generic drugs for common conditions like high blood pressure and anxiety.
The companies will link their data capabilities to provide life science firms insight into social risk drivers.